Integrative Strategies in Breast Cancer: Synergizing Modern Oncology and Ayurveda
DOI:
https://doi.org/10.64252/ktnspa21Keywords:
Ayurveda, Rasayana, Chemotherapy, Herb-drug interactions, Personalized treatment, Panchakarma, Breast cancer, Integrative oncology, and Holistic careAbstract
Background: Breast cancer is still the most common cancer in women worldwide, and as its incidence and survival rate rise, more thorough, patient-centered care models are needed. Even though contemporary oncology provides evidence-based procedures, tailored medicines, and sophisticated diagnostic tools, it frequently fails to address long-term quality of life, immunological resilience, and overall well-being. Although India's traditional medical system, Ayurveda, offers centuries-old methods for systemic healing, little is known about how it might be integrated with oncology.
Objective: This review is to assess the therapeutic potential of an integrated approach to breast cancer therapy that blends Ayurvedic and contemporary oncology principles. Additionally, it intends to provide a path for safe, evidence-based clinical practice.
Methods: The Cochrane Library, AYUSH Research Portal, PubMed, and Scopus databases were used to do a literature evaluation. Research on Ayurvedic and conventional cancer treatment was reviewed, including studies on clinical models, pharmacovigilance, diagnostics, and therapies. Important Ayurvedic ideas were mapped against biological frameworks, including Prakriti-based therapies, Panchakarma, and Rasayana.
Results: Despite advancements in molecular profiling, immunotherapy, and tailored medication, survivors continue to experience problems such immunological malfunction, exhaustion, and psychological discomfort. When applied carefully, ayurvedic treatments have shown promise in boosting immune function, decreasing inflammation, increasing chemotherapy tolerance, and improving quality of life. Pilot studies, institutional programs, and case studies all point to the early advantages of integrative approaches. Standardization, research on herb-drug interactions, regulatory procedures, and interdisciplinary communication still face difficulties, nonetheless.
Conclusion: A potential paradigm for all-encompassing breast cancer care is provided by a synergistic model that combines the accuracy of modern oncology with the holistic basis of Ayurveda. To create a long-lasting framework for integrative oncology, future studies must concentrate on clinical validation, safety monitoring, systems biology techniques, and policy-level integration.




